H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 251 Citations 313,322 1,090 World Ranking 13 National Ranking 11

Research.com Recognitions

Awards & Achievements

2020 - Member of the National Academy of Medicine (NAM)

2013 - Distinguished Scientist Award, American Heart Association

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

Paul M. Ridker mostly deals with Internal medicine, Endocrinology, Myocardial infarction, C-reactive protein and Risk factor. He combines subjects such as Surgery and Cardiology with his study of Internal medicine. He has researched Endocrinology in several fields, including Odds ratio and Genome-wide association study.

His Myocardial infarction research focuses on subjects like Disease, which are linked to Intensive care medicine and Bioinformatics. His C-reactive protein research incorporates elements of Gastroenterology, Framingham Risk Score and Metabolic syndrome. His research integrates issues of Clinical trial, Epidemiology, Relative risk, Blood pressure and Vascular disease in his study of Risk factor.

His most cited work include:

  • Inflammation and Atherosclerosis (6124 citations)
  • C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women (5151 citations)
  • Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men (4886 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Endocrinology, C-reactive protein, Myocardial infarction and Cardiology. The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Surgery. His Endocrinology research is multidisciplinary, relying on both Gastroenterology, Rosuvastatin and Odds ratio.

Paul M. Ridker regularly ties together related areas like Vascular disease in his C-reactive protein studies. His Myocardial infarction study combines topics in areas such as Stroke, Aspirin, Epidemiology and Cohort. Paul M. Ridker has included themes like Framingham Risk Score and Blood pressure in his Cardiology study.

He most often published in these fields:

  • Internal medicine (64.51%)
  • Endocrinology (21.60%)
  • C-reactive protein (18.57%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (64.51%)
  • Genome-wide association study (18.84%)
  • Genetics (21.05%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Genome-wide association study, Genetics, Disease and Hazard ratio. His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Oncology. As part of the same scientific family, Paul M. Ridker usually focuses on Genetics, concentrating on Meta-analysis and intersecting with Risk factor.

His study in Disease is interdisciplinary in nature, drawing from both Inflammation, Epidemiology and Cohort. His Hazard ratio study combines topics from a wide range of disciplines, such as Gastroenterology, Cancer, Prospective cohort study and Odds ratio. His studies in Myocardial infarction integrate themes in fields like Stroke, Diabetes mellitus and Coronary artery disease.

Between 2017 and 2021, his most popular works were:

  • Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries (799 citations)
  • Low-Dose Methotrexate for the Prevention of Atherosclerotic Events (402 citations)
  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. (284 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

His primary areas of study are Internal medicine, Genome-wide association study, Genetics, Hazard ratio and Genetic association. His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Oncology. Paul M. Ridker combines subjects such as Genetic architecture, Mendelian Randomization Analysis, Polymorphism and Medical genetics with his study of Genome-wide association study.

Paul M. Ridker has researched Genetics in several fields, including Blood lipids, Cholesterol and Lipid metabolism. His Genetic association study combines topics in areas such as Pulse pressure, Blood pressure, Bioinformatics, Case-control study and Expression quantitative trait loci. The concepts of his Myocardial infarction study are interwoven with issues in Stroke, Diabetes mellitus and C-reactive protein.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Inflammation and Atherosclerosis

Peter Libby;Paul M. Ridker;Attilio Maseri.
Circulation (2002)

21200 Citations

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

Paul M Ridker;Charles H Hennekens;Julie E Buring;Nader Rifai.
The New England Journal of Medicine (2000)

7920 Citations

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Paul M Ridker;Eleanor Danielson;Jacques Genest;Antonio M. Gotto.
The New England Journal of Medicine (2008)

7489 Citations

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

Paul M. Ridker;Mary Cushman;Meir J. Stampfer;Russell P. Tracy.
The New England Journal of Medicine (1997)

7440 Citations

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker;Eleanor Danielson;Francisco A. H. Fonseca;Jacques Genest.
Obstetrical & Gynecological Survey (2009)

6000 Citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

R Altman;L Carreras;R Diaz;E Figueroa.
BMJ (1994)

5838 Citations

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Aruna D. Pradhan;JoAnn E. Manson;Nader Rifai;Julie E. Buring.
JAMA (2001)

5350 Citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Paul M. Ridker;Nader Rifai;Lynda Rose;Julie E. Buring.
The New England Journal of Medicine (2002)

4961 Citations

From Vulnerable Plaque to Vulnerable Patient A Call for New Definitions and Risk Assessment Strategies: Part I

Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells.
Circulation (2003)

4224 Citations

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen.
The New England Journal of Medicine (2017)

3989 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Paul M. Ridker

JoAnn E. Manson

JoAnn E. Manson

Harvard Medical School

Publications: 422

George Davey Smith

George Davey Smith

University of Bristol

Publications: 417

Julie E. Buring

Julie E. Buring

Brigham and Women's Hospital

Publications: 358

Bruce M. Psaty

Bruce M. Psaty

University of Washington

Publications: 356

Albert Hofman

Albert Hofman

Harvard University

Publications: 342

Børge G. Nordestgaard

Børge G. Nordestgaard

Copenhagen University Hospital

Publications: 339

Olli T. Raitakari

Olli T. Raitakari

Turku University Hospital

Publications: 337

Eric Boerwinkle

Eric Boerwinkle

The University of Texas Health Science Center at Houston

Publications: 332

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 327

Frank B. Hu

Frank B. Hu

Harvard University

Publications: 326

André G. Uitterlinden

André G. Uitterlinden

Erasmus University Rotterdam

Publications: 294

Kari Stefansson

Kari Stefansson

deCODE Genetics (Iceland)

Publications: 290

Sekar Kathiresan

Sekar Kathiresan

Harvard University

Publications: 284

Terho Lehtimäki

Terho Lehtimäki

Tampere University

Publications: 278

Naveed Sattar

Naveed Sattar

University of Glasgow

Publications: 274

Something went wrong. Please try again later.